Table 4.
Liver Tumor, Combined | HBL | HCC | |||||||
---|---|---|---|---|---|---|---|---|---|
VEGFD+ RDs (%) | ANGPT1+ RDs (%) | PDGFC+ RDs (%) | VEGFD+ RDs (%) | ANGPT1+ RDs (%) | PDGFC+ RDs (%) | VEGFD+ RDs (%) | ANGPT1+ RDs (%) | PDGFC+ RDs (%) | |
VEGF+ RDs (%) |
0.2727*
0.1310† |
–0.1384 0.4509 |
0.1983 0.2848 |
0.0175 0.9418 |
0.0781 0.7436 |
0.1182 0.6297 |
0.4830 0.1117 |
–0.1943 0.5452 |
0.0269 0.9338 |
VEGFD+ RDs (%) |
0.1810 0.3215 |
0.4308 0.0155 |
0.2055 0.3848 |
–0.1167 0.6343 |
0.2937 0.3542 |
0.7058 0.0103 |
|||
ANGPT1+ RDs (%) |
0.3880 0.0310 |
0.5445 0.0159 |
0.5229 0.0811 |
*Pearson correlation coefficient (r).
† P value.